Contact Us

EKSO BIONICS receives FDA clearance for Ekso GT™

First and only FDA cleared exoskeleton for use with stroke and spinal cord injuries from L5 to C7.*

United States

General Information


Customer Experience


Human Resources



Media Inquiries

+49 761 557834 30

Customer Relations

+49 761 557834 20

UK Customer Relations

+44 20 7060 3568

Cutting-Edge Rehab Technology

Ekso Bionics Inc. recently announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Ekso GT robotic exoskeleton for use in the treatment of individuals with hemiplegia due to stroke.

  • News